US Patent Issued to ANTARES PHARMA on Jan. 13 for "Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol" (New Jersey Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,404, issued on Jan. 13, was assigned to ANTARES PHARMA INC. (Ewing, N.J.).

"Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol" was invented by Xiaoming Chen (Westfield, N.J.) and Shaowei Ong (Belle Mead, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides aqueous formulations comprising hydrocortisone sodium phosphate and monothioglycerol. In some embodiments, the formulations comprise monobasic sodium phosphate, dibasic sodium phosphate, or disodium EDTA. The present disclosure further provides a method of treating a disease or disorder in a subject by administering the aqueou...